NLS Collaboration

Bavarian Nordic has entered into a joint collaboration with Evaxion Biotech, a Danish biotechnology company, and Technical University of Denmark (DTU), for the development of an MVA-BN-based vaccine against MRSA (Methicillin-resistant Staphylococcus aureus) using Evaxion’s computer-based technology to discover novel antigens. The same approach could potentially be used to target any other bacteria that have […]

MSD has signed a framework agreement with the Sahlgrenska Academy at the University of Gothenburg and the region Västra Götaland. The agreement is the starting point for a new collaboration arena which hopefully in the long run will benefit patients. The three collaboration partners will form a steering committee and initiate for example better identification […]

Allergan has entered into a global agreement with AstraZeneca to develop and commercialize ATM-AVI, an investigational, fixed-dose antibiotic combining aztreonam and avibactam. Together, the two companies will evaluate the combination to treat serious infections caused by metallo βlactamase MBL-producing Gram-negative pathogens, a difficult-to-treat sub-type of carbapenem-resistant Enterobacteriaceae (CRE), for which there are currently very limited […]

BC Platforms has signed a contract with Nexus Personalized Health Technologies to create a joint translational research driven offering connecting genetic and clinical information to enable new innovative patient centric solutions in healthcare. Nexus is a provider of services to biomedical researchers in bioinformatic and biostatistical data analysis and will facilitate data integration among different […]

PCI Biotech and Ultimovacs are initiating a preclinical research collaboration. The purpose of the collaboration is to utilise the companies’ complementary scientific platforms to explore potential synergies. Both companies are situated in the Oslo Cancer Cluster Incubator. The partnership is governed by a preclinical research collaboration agreement. In brief, the preclinical research collaboration will evaluate technology […]

Ferring Pharmaceuticals and Karolinska Institutet have entered a collaboration agreement for the establishment of a research center exploiting the human microbiome. The programme will be fully funded by Ferring Pharmaceuticals and governed by a joint steering committee. The proposed project focuses on therapeutic areas where Ferring has extensive expertise. Karolinska Institutet has a deep understanding of […]